A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer.

David Miles,Ke Towlson,Rosalind Graham,Mark A. Reddish,Bm Longenecker,Joyce Taylor-Papadimitriou,R.D. Rubens

A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer.

1996

David Miles
Ke Towlson
Rosalind Graham
Mark A. Reddish
Bm Longenecker
Joyce Taylor-Papadimitriou
R.D. Rubens

A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer

Keywords:

Immunology
Breast cancer
Medicine
Immunotherapy
Cancer
Pathology
Adjuvant
Detox-B adjuvant
Cyclophosphamide
Metastatic breast cancer
Chemotherapy
Subcutaneous injection
Progressive disease
Antigen
Ovine Submaxillary Mucin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations